Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients.
Evaluation of Serological Indicators and Glomerular Filtration Rate Equations in Chinese Cancer Patients.
复制标题
中国癌症患者血清学指标和肾小球滤过率方程的评价
DOI:
10.12659/msm.902138
复制
发表时间:
2017-06-17
期刊:
影响因子:
--
通讯作者:
Zhou Y
中科院分区:
文献类型:
--
作者:
Tong Y;Liu X;Guan M;Wang M;Zhang L;Dong D;Niu R;Zhang F;Zhou Y
Background The performance of estimated glomerular filtration rate (eGFR) have been proved to vary according to the races of the target population. The eGFR equations have not been validated in the Chinese cancer population received chemotherapy. Meanwhile, serum cystatin C (CysC), urea, β2 microglobulin (β2-MG), and creatinine (SCr) were also evaluated in a cohort of Chinese cancer patients. Material/Methods A total of 1000 cancer patients undergoing combination chemotherapy and 108 healthy volunteers were included in this study, and their renal function parameters were evaluated. The eGFR values were compared with reference GFR (rGFR) according to correlation, consistency, precision, and accuracy. Receiver operating characteristic (ROC) curves were used to evaluate the discriminating ability of the GFR equations and serological indicators of renal function. Results (1) The equations contained CysC had the same varying tendency as rGFR in relation to the chemotherapeutic cycle. (2) eGFRscr+cysc and eGFRChinese scr+cysc worked better than the other equations, as indicated by a stronger correlation, less bias, improved precision, higher accuracy, and greater AUC. (3) CysC was more sensitive than the other serological indicators for identifying early renal injury. (4) Each parameter showed different characteristics in subgroups of Chinese cancer patients. Conclusions CysC was the most sensitive marker for early renal injury. Among the 8 most commonly used eGFR equations, the combination equation eGFRscr+cysc and eGFRChinese scr+cysc exhibited the best performance in the assessment of the renal function of Chinese cancer patients.